Does ENZALUTAMIDE Cause Diffuse large b-cell lymphoma? 6 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Diffuse large b-cell lymphoma have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.
6
Reports of Diffuse large b-cell lymphoma with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
2
Deaths
3
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From ENZALUTAMIDE?
Of the 6 reports, 2 (33.3%) resulted in death, 3 (50.0%) required hospitalization.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which ENZALUTAMIDE Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE